Updated Date: Tue, 06 May 2025 00:00:00 EDT
Month: May 2025
Trial progresses towards topline data expected later in the year
FDA recognises KER-0193 as a potential therapy for rare paediatric disease
Updated Date: Tue, 06 May 2025 00:00:00 EDT
Updated Date: Tue, 06 May 2025 00:00:00 EDT
Updated Date: Tue, 06 May 2025 00:00:00 EDT
Updated Date: Tue, 06 May 2025 00:00:00 EDT
Updated Date: Mon, 05 May 2025 00:00:00 EDT
Updated Date: Mon, 05 May 2025 00:00:00 EDT
Updated Date: Mon, 05 May 2025 00:00:00 EDT